Retinal Diseases: all 817 studies
Page 8 of 9. Open to participants first (104), then studies with results posted, then the rest; newest registration first within each.
- Recombinant Erythropoietin for Neuroprotection in Very Preterm InfantsStatus unknownNCT00910234Phase 1/2
- A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy SubjectsStatus unknownNCT00908778Phase 3
- Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic RetinopathyCompletedNCT00907114Phase 2
- Visual Function, Center Point Thickness and Macular Volume After PhotocoagulationCompletedNCT00906659
- A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic RetinopathyCompletedNCT00904592Not applicable
- Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular EdemaCompletedNCT00900887Phase 2
- Pain in Neonates During Screening for Retinopathy of Prematurity Using Two MethodsCompletedNCT00895869
- Diabetic Macular Edema Severity at DiagnosisCompletedNCT00886392
- Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 DiabetesTerminatedNCT00880139
- Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)No longer availableNCT00870636
- Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot StudyStatus unknownNCT00855608Phase 1
- A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye DiseaseWithdrawnNCT00853424Phase 3
- Time Outside Target Oxygen Saturation Range in Preterm Infants and Long Term Outcomes and Preterm InfantsCompletedNCT00845624
- Phenotyping Diabetic RetinopathyCompletedNCT00840541
- Retinal Function in Diabetic Patients Without RetinopathyCompletedNCT00839150
- Management of Diabetes Mellitus Patients With RetinopathyCompletedNCT00828425
- Clinical Trial of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 MutationsCompletedNCT00821340Phase 1
- Effect of Levodopa on Human Multifocal ElectroretinogramCompletedNCT00812760Phase 4
- Treatment Of Radiation Retinopathy TrialStatus unknownNCT00811200Phase 2/3
- Combined Triple Therapy in Diabetic Retinopathy (DRP)CompletedNCT00806169Phase 3
- Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabCompletedNCT00804921Phase 2
- Transcorneal Electrical Stimulation Therapy for Retinal DiseaseCompletedNCT00804102Not applicable
- Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy.TerminatedNCT00802269Phase 4
- Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO PopulationCompletedNCT00799695Not applicable
- Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence TomographyCompletedNCT00797524
- Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal BevacizumabCompletedNCT00776763Phase 2
- Effect of Panretinal Photocoagulation on Optic Nerve Head TopographyTerminatedNCT00767884
- Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2CompletedNCT00763802
- Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal MelanomaCompletedNCT00750399Phase 1
- Macular Hole in Diabetic RetinopathyCompletedNCT00737074
- Anesthesia for Pars Plana Vitrectomy (PPV) With Insulin NeedleCompletedNCT00735657Not applicable
- Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular AngiogenesisCompletedNCT00728598
- Diabetic Retinopathy and Sickle TraitCompletedNCT00720317
- Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM)TerminatedNCT00718614Not applicable
- Neurovascular Coupling in Patients With Early Stage Diabetes RetinopathyCompletedNCT00712842
- Pan-VEGF Blockade for the Treatment of Retinopathy of PrematurityTerminatedNCT00702819Phase 1
- Study on Tear Proteins in Diabetic Retinopathy of Type 2 DiabeticsStatus unknownNCT00698698
- Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)CompletedNCT00690768Phase 2
- Morphological and Functional Retinal Changes Following Retinal PhotocoagulationCompletedNCT00682240Phase 4
- Effects of Copaxone in the Retinal Function in Diabetic Patients After PanphotocoagulationStatus unknownNCT00677664Phase 4
- Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyCompletedNCT00665106Phase 1
- A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy SubjectsTerminatedNCT00664183Phase 2/3
- Bevacizumab and Long Acting Gas in Diabetic VitrectomyCompletedNCT00656435Phase 3
- Pain Response During Examination for Retinopathy of PrematurityCompletedNCT00648687Not applicable
- Genetics and Markers of Degenerative and Inflammatory Eye DiseasesCompletedNCT00647439
- Inhaled Nitrous Oxide for Pain Relief During Eye Exam in the Pre-term InfantCompletedNCT00623220Phase 3
- Pharmacological Intervention in Diabetic RetinopathyCompletedNCT00619034Not applicable
- Ranibizumab for Neovascularization in Sickle Cell RetinopathyWithdrawnNCT00618644Not applicable
- Intravitreal Bevacizumab for Diabetic RetinopathyTerminatedNCT00600262Phase 2/3
- HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican PopulationWithdrawnNCT00600236Phase 3
- Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic VitrectomyCompletedNCT00596505
- Preoperative Bevacizumab for Vitreous HemorrhageCompletedNCT00596297Phase 1/2
- Changes in Macular Thickness After Patterns Scan LaserTerminatedNCT00563628Phase 4
- VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and VWithdrawnNCT00563121Phase 4
- Changes in Electroretinogram and Contrast Sensitivity After PASCAL TreatmentTerminatedNCT00563043Phase 4
- Bevacizumab Versus Ranibizumab for Diabetic RetinopathyCompletedNCT00545870Phase 3
- Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic PatientsStatus unknownNCT00524875Not applicable
- Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring VitrectomyStatus unknownNCT00516464Phase 3
- Treatment of Refractory Diabetic Macular Edema With InfliximabTerminatedNCT00505947Phase 3
- Vascular Endothelial Growth Factor in Stage V ROPTerminatedNCT00500396Phase 4
- Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited TrainingCompletedNCT00500097Not applicable
- Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care ProgramStatus unknownNCT00498147
- Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 MutationsCompletedNCT00481546Phase 1
- Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)CompletedNCT00446381Not applicable
- Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT00443521Phase 2/3
- UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane BlueCompletedNCT00437593Not applicable
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT00423059Not applicable
- Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal DystrophyCompletedNCT00422721Not applicable
- Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic RetinopathyCompletedNCT00411333Early Phase 1
- Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic RetinopathyWithdrawnNCT00407108Phase 3
- Retinal Blood Flow and Microthrombi in Type 1 DiabetesCompletedNCT00406991Phase 2
- Intravitreal Bevacizumab for Retinal DisordersStatus unknownNCT00403026Not applicable
- Efficacy Study of Lucentis in the Treatment of Diabetic Macular EdemaCompletedNCT00387582Phase 2
- Metabolic Mapping to Measure Retinal MetabolismCompletedNCT00385333Phase 2
- Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical TrialCompletedNCT00370851Phase 3
- Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)Status unknownNCT00370721Phase 3
- Green Laser Photocoagulation Study in Proliferative Diabetic RetinopathyCompletedNCT00355680Phase 3
- Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyWithdrawnNCT00347698Phase 2/3
- Erythropoietin and Early Iron Supplement and Retinopathy of PrematurityStatus unknownNCT00339001
- The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 DiabetesCompletedNCT00337298Not applicable
- A Pilot Study for the Treatment of Iris Neovascularization With MacugenCompletedNCT00295828Phase 1
- Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of PrematurityCompletedNCT00279669
- Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)TerminatedNCT00278486Phase 1
- Microvascular Reactivity.CompletedNCT00259701
- Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyTerminatedNCT00248157Phase 3
- Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyTerminatedNCT00248131Phase 3
- Triamcinolone Acetonide Injections to Treat Diabetic Macular EdemaCompletedNCT00231023Phase 2
- Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)TerminatedNCT00211406Phase 1
- Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous DetachmentCompletedNCT00198471Phase 2
- Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsCompletedNCT00174824Phase 4
- Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.TerminatedNCT00170742Phase 3
- Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic VitrectomyCompletedNCT00155454Not applicable
- Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNCT00131144Phase 3
- Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNCT00130845Phase 3
- Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With DiabetesCompletedNCT00119535Not applicable
- Clinical and Genetic Studies of Familial Exudative VitreoretinopathyCompletedNCT00106756
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Optical Coherence Tomography Comparative StudyCompletedNCT00069199
- Research Study in Patients With Persistent Macular EdemaCompletedNCT00035906Phase 2
- The Early Treatment for Retinopathy of Prematurity Study (ETROP)Status unknownNCT00027222Phase 2/3